The agency said the gummies were particularly concerning because they resemble kid-friendly candy products and they can cause severe nicotine toxicity or even death in young children.
- A company that made illegal flavored nicotine gummies has discontinued the item following a warning letter from the U.S. Food and Drug Administration.
The FDA sent a letter last month to VPR Brands, the name behind Krave Nic, warning the company was not authorized to make, sell or distribute such products. The gummies contained one milligram of nicotine and came in three different flavors, such as “blue razz” and “cherry bomb.”The FDA said such gummies are “a public health crisis just waiting to happen among our nation’s youth.”
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Nicotine gummies removed after FDA warningKrave Nic said its products are being discontinued after receiving a letter from the Food and Drug Administration over the marketing of its products.
Weiterlesen »
Nicotine gummies are a 'public health crisis just waiting to happen,' FDA says | CNNFirst, there were flavored cigarettes that tasted like chocolate or grape. Then came the e-cigarettes in flavors like cotton candy or gummy bear. Now, there are flavored gummies made with nicotine, and the US Food and Drug Administration isn't happy about it.
Weiterlesen »
U.S. FDA approves bluebird bio's gene therapy for a rare neurological disorderThe U.S. Food and Drug Administration (FDA) has approved Bluebird bio's gene therapy for the treatment of a rare neurological disorder, the company said late on Friday.
Weiterlesen »
Toyota Reportedly Discontinuing C-HR In Canada For 2023 | CarscoopsToyota Reportedly Discontinuing C-HR In Canada For 2023 | Carscoops carscoops
Weiterlesen »
FDA warns monkeypox could mutate to resist antiviral drugU.S. health officials are warning against overuse of the lone drug currently available against monkeypox, saying that even a small mutation to the virus could render the medication ineffective.
Weiterlesen »
'A devil's bargain': FDA's drug industry fees fuel concerns over influenceThe pharmaceutical industry funding alone has become so dominant that last year it accounted for three-quarters — or $1.1 billion — of the agency’s drug division budget.
Weiterlesen »